Filing Details
- Accession Number:
- 0001562180-21-006415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-12 16:49:37
- Reporting Period:
- 2021-10-08
- Accepted Time:
- 2021-10-12 16:49:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1531048 | Inari Medical Inc. | NARI | Surgical & Medical Instruments & Apparatus (3841) | 452902923 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1644989 | Hill, Mitch C. | C/O Inari Medical, Inc. 6001 Oak Canyon, Suite 100 Irvine CA 92618 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-08 | 5,000 | $0.46 | 92,715 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-10-08 | 1,299 | $78.43 | 91,416 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-10-08 | 3,401 | $79.58 | 88,015 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-10-08 | 300 | $80.18 | 87,715 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2021-10-08 | 5,000 | $0.00 | 5,000 | $0.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 256,977 | 2029-04-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,600 | Indirect | By spouse |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020
- This transaction was executed in multiple trades at prices ranging from $78.11 to $79.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $79.12 to $80.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $80.12 to $80.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Options vested with respected with 25% of the underlying shares on April 30,2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.
Billionaire Hedge Funds
